Experience

ECO ANIMAL HEALTH GROUP PLC

• United Kingdom
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chairman

  • Mar 2019 - Present

  Branded medicines for large animals Branded medicines for large animals



Anpario plc

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• Senior NED

  • Oct 2017 - Present

  Specialist animal feed additives Specialist animal feed additives



Third Bridge Consulting

• UK

• International Business and Investment Consultant

  • Jan 2016 - Present

  Agriculture, Genetics, Defence, Rubber technology, Milking Equipment Agriculture, Genetics, Defence, Rubber technology, Milking Equipment



GLG

• United States
• Information Services
• 700 & Above Employee

• International Business Consultant

  • Oct 2011 - Present

  Agriculture, Genetics, business development and trouble shooting Agriculture, Genetics, business development and trouble shooting



Atlantic Pharmaceuticals ltd

• Chairman

  • 2011 - 2017

  Developing drug for inflamatory bowel deseases Developing drug for inflamatory bowel deseases



Ocean Harvest Technology Inc

• British Columbia, Canada

• Chairman

  • Nov 2015 - Dec 2016

  develop and manufacture therapeutic animal feeds from seaweeds develop and manufacture therapeutic animal feeds from seaweeds



Avon Protection plc

• United Kingdom
• Defense & Space
• 200 - 300 Employee

• Senior NED and Chairman of Remuneration

  • Dec 2012 - Mar 2016

  Manufacturer of speciality rubber products for defence industry and dairy milking machines Manufacturer of speciality rubber products for defence industry and dairy milking machines



Silent Herdsman/ Afimilk Ltd

• United Kingdom
• Biotechnology
• 1 - 100 Employee

• Chairman

  • Oct 2014 - Feb 2016

  Non-Executive chairman of Board and liaison with shareholders. Divested as a trade sale in February 2016 Non-Executive chairman of Board and liaison with shareholders. Divested as a trade sale in February 2016



Innovis ltd

• Chairman

  • 2011 - Jun 2014

  Biotechnology in Sheep genetics Biotechnology in Sheep genetics



Genus plc

• Worlwide

• Chief Executive

  • 1997 - 2011

  Genus is a FTSE 250 company with a market cap. of £850m, an International turnover of £350 million and employing 3000 staff. Operations in 30 countries include the USA, UK and Europe, China and the Far East, Australia and Latin America. Genus is now the world’s leading animal genetics company. It spends £25 million/year on R&D and uses leading edge biotechnology to enhance its genetics programmes. Semen or breeding animals are sold to farmers in 70 countries to improve output, profitability and to meet the quality or consistency requirements of contracts with food processors. Achievements:- • Developed from the government privatisation of a £35m/year UK only business a technology driven world market leader in animal genetic. • Expanded operations by organic growth and selective acquisitions including a public offering for Sygen plc for £187m • Floated on OFEX, AIM and Main Market • Managed fund raisings and a restructuring of the shareholder base • Increased share price from 50 pence in 1997 to £11.5 on retirement • Awarded Techmark company of the year in 2008 • Awarded CEO of the year in 2011 Show less



Daniels Pharmaceutical ltd

• Chief Executive

  • 1989 - 1996

  Turnover £350 million, 2300 staff in 14 UK locations. Daniels manufactured human pharmaceuticals, especially sterile opthalmics, creams and ointments. Its R&D expenditure of £1 million per year was used to copy, “out of patent”, propriety pharmaceuticals. The licensed generics produced were sold in competition with the brand leaders in 30 countries of the world. Achievements:- • Increased turnover from £35 million per year to £350 million per year • Introduced 20 new products • Set up contract manufacturing for Glaxo, Fisons, Boots and both the UK and Hong Kong National Health Services • Sold to Lloyds Chemists plc and became Division Managing Director at Lloyds. Show less